DocCheck AG (HAM:AJ91) Tariff Resilience Score: 0/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:AJ91 DocCheck AG HAM:AJ91
71 GF Score
Price €11.90
GF Value €9.52
! 3 Warning Signs
View Full Analysis

What is DocCheck AG Tariff Resilience Score?

DocCheck AG has the Tariff Resilience Score of 0, which implies that the company might have .

DocCheck AG has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes DocCheck AG might have .

DocCheck AG  (HAM:AJ91) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

DocCheck AG Tariff Resilience Score Related Terms

HAM:AJ91
71GF Score
DocCheck AG HAM:AJ91
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DocCheck AG (HAM:AJ91) Overvalued in 2026?

Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued. The current stock price of €11.90 is trading 25% above its estimated GF Value™ of €9.52.

Key valuation signals for HAM:AJ91:

  • Tariff Resilience Score: 0
  • GF Value™: €9.52 vs. price of €11.90 (25% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the HAM:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DocCheck AG Business Description

Other Exchanges AJ91:Germany
Address Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score

Get the complete analysis for HAM:AJ91

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.90
Price
€9.52
GF Value